Accelevir Diagnostics
United States of America (USA)
1 June 2019 - 31 May 2020
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Accelevir Diagnostics published between 1 June 2019 - 31 May 2020 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
| Count | Share |
|---|---|
| 1 | 0.02 |
Outputs by subject (Share)
| Subject | Count | Share | |
|---|---|---|---|
| Life Sciences | 1 | 0.02 | |
Top articles by Altmetric score in current window
The Landscape of Persistent Viral Genomes in ART-Treated SIV, SHIV, and HIV-2 Infections
Cell Host & Microbe
2019-07-10
1 June 2019 - 31 May 2020
International vs. domestic collaboration by Share
- 94.92% Domestic
- 5.08% International
Note: Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators by Share (7 total)
- Accelevir Diagnostics, United States of America (USA)
- Domestic institution
-
Johns Hopkins University (JHU), United States of America (USA)
(0.63)
-
Frederick National Laboratory for Cancer Research (FNLCR), United States of America (USA)
(0.10)
-
Harvard University, United States of America (USA)
(0.10)
-
Oregon Health and Science University (OHSU), United States of America (USA)
(0.10)
-
University of Washington (UW), United States of America (USA)
(0.10)
-
Leidos Holdings, Inc., United States of America (USA)
(0.06)
-
National Institutes of Health (NIH), United States of America (USA)
(0.06)
Top 10 international collaborators by Share (1 total)
- Accelevir Diagnostics, United States of America (USA)
- Foreign institution
-
CHU Fann (CHNUF), Senegal
(0.06)
Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
